Thyroid cytopathology: Bethesda and beyond.

Area of Science:

• Cytopathology
• Endocrinology
• Surgical Oncology

Background:

• Thyroid nodules are common, with most being benign, but accurate identification of malignant cases is crucial for timely intervention.
• Fine-needle aspiration (FNA) is the primary diagnostic tool for differentiating benign and malignant thyroid nodules pre-operatively.

Purpose of the Study:

• To highlight the standardization of thyroid nodule diagnosis and reporting through the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
• To discuss the clinical utility and management algorithms associated with TBSRTC categories.
• To explore the role of molecular markers in addressing indeterminate cytopathologic diagnoses.

Main Methods:

• Review of the diagnostic criteria and reporting structure of the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
• Analysis of clinical management guidelines and their integration with TBSRTC.
• Examination of emerging molecular markers for indeterminate thyroid nodule cases.

Main Results:

• The TBSRTC provides standardized cytomorphological criteria and diagnostic categories with defined risks of malignancy.
• TBSRTC has demonstrated wide acceptance and clinical utility among pathologists and clinicians.
• Molecular markers, such as BRAF, show promise in refining the diagnosis of indeterminate thyroid nodules.

Conclusions:

• The TBSRTC has standardized thyroid nodule diagnosis, facilitating improved patient management and surgical planning.
• The system's defined categories and associated management algorithms enhance clinical decision-making.
• Ongoing research into molecular markers holds potential for further improving the diagnostic accuracy of indeterminate thyroid lesions.